Lumen Bioscience co-founders Jim Roberts (left) and Brian Finrow
Lumen lands another DoD contract to treat Covid-related GI issues
The team at Lumen Bioscience believes that it can help patients, including those infected with Covid-19, through its plant-based drug LMN-301. Wednesday, it
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
